Product Name: DTNA Antibody
Species Reactivity: Mouse
Tested Applications: IF, IHC-P, WB
Applications: For WB starting dilution is: 1:1000For IHC-P starting dilution is: 1:10~50For IF starting dilution is: 1:10~50
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 84 kDa
Immunogen: This DTNA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 692-721 amino acids from the C-terminal region of human DTNA.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 957890-42-5
Product: HIV-1 integrase inhibitor 2
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.38 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: Dystrobrevin alpha, DTN-A, Alpha-dystrobrevin, Dystrophin-related protein 3, DTNA, DRP3
Accession NO.: Q9Y4J8
Protein Ino: 229462840
Official Symbol: DTNA
Geneid: 1837
Background: The protein encoded by this gene belongs to thedystrobrevin subfamily of the dystrophin family. This protein is acomponent of the dystrophin-associated protein complex (DPC), whichconsists of dystrophin and several integral and peripheral membraneproteins, including dystroglycans, sarcoglycans, syntrophins andalpha- and beta-dystrobrevin. The DPC localizes to the sarcolemmaand its disruption is associated with various forms of musculardystrophy. Mutations in this gene are associated with leftventricular noncompaction with congenital heart defects. Multiplealternatively spliced transcript variants encoding differentisoforms have been identified for this gene.
PubMed ID:http://aac.asm.org/content/39/1/132.abstract
